The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Co-mutations of DNA damage response system as predictive biomarker for immune checkpoint blockades.
 
Zhijie Wang
No Relationships to Disclose
 
Jing Zhao
Employment - 3D Medicines
 
Guoqiang Wang
Employment - 3D Medicines
 
Fan Zhang
No Relationships to Disclose
 
Yuzi Zhang
Employment - 3D Medicines
 
Hua Dong
Employment - 3D Medicines
 
Xiaochen Zhao
Employment - 3D Medicines
 
Jianchun Duan
No Relationships to Disclose
 
Hua Bai
No Relationships to Disclose
 
Yanhua Tian
No Relationships to Disclose
 
Rui Wan
No Relationships to Disclose
 
Lei Xiong
Employment - 3D Medicines
 
Shangli Cai
Employment - 3D Medicines
 
Tony Mok
Employment - The Chinese University of Hong Kong
Leadership - Sanomics Limited
Stock and Other Ownership Interests - Cirina; Sanomics Limited
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Cirina; Clovis Oncology; geneDecode; Ignyta; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Oncogenex; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Vertex
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SFJ Pharmaceuticals Group (Inst); Taiho Pharmaceutical (Inst)
 
Jie Wang
No Relationships to Disclose